Funding, News and Announcements

Pfizer is interested in supporting research proposals that advance our understanding of ulcerative colitis through research focused in the following areas:

• For patients treated with S1P receptor modulators, exploration for optimal markers (including clinical, endoscopic, histologic, ultrasonographic, genetics, and other measured markers) to assess and potentially predict response to treatment
• Correlation of effects of S1P receptor modulator and Microbiome
• Elucidate the role of S1P receptor modulators in the treatment of extra-intestinal manifestations (EIM) of UC
• Assess mechanistic association of S1P receptor modulation with reduced inflammation in colonic tissue beyond lymphocyte egress

Individual projects requesting up to $200,000 USD will be considered.

Full details of the call are available here.

Internal Deadline: August 29, 2023 at 4:30pm. Contact email is ird@dal.ca. For additional resources, click here for guidance on internal deadlines and submission processes.

Funder Deadline: September 12, 2023.